Journal Article

DKFZ-2024-01946

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Discovery of BAY-405: An Azaindole-Based MAP4K1 Inhibitor for the Enhancement of T-Cell Immunity against Cancer

Mowat, J. ; Carretero, R.DKFZ* ; Leder, G. ; Aiguabella Font, N. ; Neuhaus, R.DKFZ* ; Berndt, S. ; Günther, J. ; Friberg, A. ; Schäfer, M. ; Briem, H. ; Raschke, M. ; Miyatake Ondozabal, H. ; Buchmann, B. ; Boemer, U. ; Kreft, B. ; Hartung, I. V. ; Offringa, R. (Last author)DKFZ*

2024
ACS Washington, DC

This record in other databases:  

Please use a persistent id in citations: doi:10.1021/acs.jmedchem.4c01325

Note: #LA:D220#LA:D200# / 2024 Oct 10;67(19):17429-17453

---

Contributing Institute(s):

1. DKFZ -Bayer Healthcare Joint (D220)
2. Molekulare Grundlagen Gastrointestinaler Tumoren (D200)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2024

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Chemical Reactions ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; Index Chemicus ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---